secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2026-10-20T20:30:38+00:00
Accession:  0001005286-26-000040
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Lifecore sets Nov 4 record date for special meeting to vote on Sept 27 merger with Lifecore Inc.
--------------------------------------------------------------------------------

- Board established November 4, 2026 as record date for a special stockholder meeting to approve adoption of the Merger Agreement and the merger.
- Merger Agreement, dated September 27, 2026, is among Lifecore Biomedical, Inc., Lifecore Inc. and Hazel Merger Sub, Inc.
- Company will file preliminary and definitive proxy statements with the SEC; no deal price, premium or expected closing date disclosed here.
- Directors and executive officers may be deemed solicitation participants; their holdings are detailed in the April 24, 2026 annual proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528626000040/0001005286-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528626000040/lfcr-20261016.htm
  HTML page:      https://secwatch.observer/filing/0001005286-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer